Humanized antibodies
    2.
    发明授权
    Humanized antibodies 失效
    人源化抗体

    公开(公告)号:US07696324B2

    公开(公告)日:2010-04-13

    申请号:US11519322

    申请日:2006-09-11

    IPC分类号: C07K16/28 C12P21/08

    摘要: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.

    摘要翻译: 提供了结合ICAM-1的人源化抗体。 抗体包括选自:SEQ ID NO:1和3(HumA)的那些; SEQ ID NO:5和7(HumB); SEQ ID NO:9和11(HumC); SEQ ID NO:13和15(HumD); SEQ ID NO:17和19(HumE); SEQ ID NO:21和23(HumF); SEQ ID NO:25和27(HumG); SEQ ID NO:29和31(HumH); 和SEQ ID NO:33和35(HumI)。 还提供了能够结合ICAM-1表位的人源化抗体的子序列。 还提供了使用能够结合ICAM-1表位的人源化抗体抑制细胞病原体感染(例如HRV)的方法。

    HUMANIZED ANTIBODIES
    4.
    发明申请
    HUMANIZED ANTIBODIES 失效
    人类抗体

    公开(公告)号:US20110044976A1

    公开(公告)日:2011-02-24

    申请号:US12748304

    申请日:2010-03-26

    摘要: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.

    摘要翻译: 提供了结合ICAM-1的人源化抗体。 抗体包括选自:SEQ ID NO:1和3(HumA)的那些; SEQ ID NO:5和7(HumB); SEQ ID NO:9和11(HumC); SEQ ID NO:13和15(HumD); SEQ ID NO:17和19(HumE); SEQ ID NO:21和23(HumF); SEQ ID NO:25和27(HumG); SEQ ID NO:29和31(HumH); 和SEQ ID NO:33和35(HumI)。 还提供了能够结合ICAM-1表位的人源化抗体的子序列。 还提供了使用能够结合ICAM-1表位的人源化抗体抑制细胞病原体感染(例如HRV)的方法。

    Humanized antibodies
    8.
    发明申请
    Humanized antibodies 失效
    人源化抗体

    公开(公告)号:US20070071742A1

    公开(公告)日:2007-03-29

    申请号:US11519322

    申请日:2006-09-11

    IPC分类号: A61K39/395 C12N5/06 C12N5/16

    摘要: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.

    摘要翻译: 提供了结合ICAM-1的人源化抗体。 抗体包括选自:SEQ ID NO:1和3(HumA)的那些; SEQ ID NO:5和7(HumB); SEQ ID NO:9和11(HumC); SEQ ID NO:13和15(HumD); SEQ ID NO:17和19(HumE); SEQ ID NO:21和23(HumF); SEQ ID NO:25和27(HumG); SEQ ID NO:29和31(HumH); 和SEQ ID NO:33和35(HumI)。 还提供了能够结合ICAM-1表位的人源化抗体的子序列。 还提供了使用能够结合ICAM-1表位的人源化抗体抑制细胞病原体感染(例如HRV)的方法。